The Patent Finder

Astellas Pharma GmbH

Also on record
Records under this name other than patents Astellas Pharma GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Astellas Pharma GmbH

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,077,534Production of pharmaceutical formulations for treatment of edema and venous disorders
Term ended
Term ended Sep 2, 2017 · USPTO record
Term endedTerm ended Sep 2, 2017USPTO record
US 7,320,993Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic useful as cytostatic and immuosuppressive agents
Formerly held
Lapsed on the fee record
Ended Jan 22, 2016 · USPTO record
Lapsed on the fee recordEnded Jan 22, 2016USPTO record
US 7,276,524Pyridyl alkane acid amides as cytostatics and immunosuppressives
Formerly held
Lapsed on the fee record
Ended Oct 2, 2015 · USPTO record
Lapsed on the fee recordEnded Oct 2, 2015USPTO record
US 6,593,344Piperadinyl-substituted pyridylalkane, alkene and alkine carboxamides
Formerly held
Lapsed on the fee record
Ended Jul 15, 2015 · USPTO record
Lapsed on the fee recordEnded Jul 15, 2015USPTO record
US 7,241,745Pyridyl alkene and pyridyl alkine acid amides as cytostatics and immunosupressives
Formerly held
Lapsed on the fee record
Ended Jul 10, 2015 · USPTO record
Lapsed on the fee recordEnded Jul 10, 2015USPTO record
US 7,192,967Cyclic imide-substituted pyridylalkane, alkene, alkine carboxamides useful as cytostatic and immunosuppressive agents
Formerly held
Lapsed on the fee record
Ended Mar 20, 2015 · USPTO record
Lapsed on the fee recordEnded Mar 20, 2015USPTO record
US 6,506,572Inhibitors of cellular niacinamide mononucleotide formation and their use in cancer therapy
Formerly held
Lapsed on the fee record
Ended Jan 14, 2015 · USPTO record
Lapsed on the fee recordEnded Jan 14, 2015USPTO record
US 6,451,816Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression
Formerly held
Lapsed on the fee record
Ended Sep 17, 2014 · USPTO record
Lapsed on the fee recordEnded Sep 17, 2014USPTO record
US 6,444,823Pyridyl alkane acid amides as cytostatics and immunosuppressives
Formerly held
Lapsed on the fee record
Ended Sep 3, 2014 · USPTO record
Lapsed on the fee recordEnded Sep 3, 2014USPTO record
US 6,903,118Piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides
Formerly held
Lapsed on the fee record
Ended Jun 7, 2013 · USPTO record
Lapsed on the fee recordEnded Jun 7, 2013USPTO record
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited